Abbott To Acquire Facet Biotech
Posted on | March 10, 2010 | 1 Comment
Abbott has agreed to acquire Facet Biotech for $27 per share in cash for a net transaction value of approximately $450m to enhance its early- and mid-stage pharmaceutical pipeline.
Comments
One Response to “Abbott To Acquire Facet Biotech”
Recommended Vendors
FDA What’s New
World Pharma
- Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS®
- Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
- Bristol-Myers Squibb to Acquire ZymoGenetics
- Roche announces Operational Excellence initiative
March 10th, 2010 @ 6:46 pm
[...] BOSTON — Facet Biotech Corp. and InterMune Inc. were the lead advancers among biotech stoFacet Biotech – 03/10/10 – Facet Biotech is up 66.44%, on a $27 per share cash offer for the company, by Abbot [...]